Faculty:
L. Jay Katz, MD
Director of Glaucoma Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Philadelphia, PA
Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
The contents of this activity derives from Hawaiian Eye 2016 which took place on January 16-22, 2016. Disclosures for faculty are accurate as of the time of the live meeting.
Faculty member reports the following relationship(s):
L. Jay Katz, MD
Consulting Fees: Aerie Pharmaceuticals, Alcon Laboratories, Inc., Alimera Sciences, Allergan, Inc., Bausch + Lomb, Inc., ForSight Vision Glaukos Corporation, Inotek Corporation, Mati Therapeutics, Ocular Therapeutix, Sensimed AG, Sucampo
Speakers Bureau: Alcon Laboratories, Inc., Allergan, Inc., Lumenis, Merck & Co., Inc.
Contracted Research: Aerie Pharmaceuticals, Allergan, Inc., Bausch + Lomb, Inc., InnFocus Inc., Mati Therapeutics
Ownership Interest: Aerie Pharmaceuticals, Glaukos Corporation, Mati Therapeutics
(Medical Monitor): Glaukos Corporation
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.